SCHEMBL10157906

SCHEMBL10157906

C1=CC2=C(CC1)OCCC2

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.33
CA9 Q16790 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13679592 0.86
SCHEMBL16511466 0.68 CA1 (0.41) CA1CA9
SCHEMBL3686374 0.67
SCHEMBL11912057 0.67 ALDH1A1 (0.44) CA1CA9
SCHEMBL14591129 0.65
SCHEMBL17526395 0.65 CA1 (0.33) CA1CA9
SCHEMBL18946007 0.64
SCHEMBL8526621 0.64
SCHEMBL20171032 0.64
SCHEMBL16689076 0.64 CA1 (0.38) CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024016826-A1 6-POSITION SUBSTITUTED DIHYDROBENZO[E][1,2,3]OXATHIAZINE 2,2-DIOXIDE COMPOUND, PREPARATION THEREFOR, AND USE THEREOF 杭州市第七人民医院 2024-01-25 WO claimed
EP-2767281-A1 BASE POWDER FROM THE RED RASPBERRY RUBUS IDAEUS AND ACTIVATED MICRONIZED ZEOLITE FOR ATTENUATING NICOTINE ADDICTION, METHOD FOR THE PREPARATION THEREOF AND USE THEREOF Universidad Autonoma del Estado de Hidalgo (MX) 2014-08-20 EP disclosed
EP-2220076-B1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BOEHRINGER INGELHEIM INT (DE) 2012-01-18 EP disclosed
EP-1658066-B9 ADAMANTYLGLYCINE- BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV FOR THE TREATMENT OF DIABETES BRISTOL MYERS SQUIBB CO (US) 2010-02-24 EP disclosed